Friday, January 08, 2010 7:02:50 PM
What happened here was GOOD SCIENCE... which, unfortunately for share holders, generated some seriously good and important learning points about the issues they studied, which ended up showing that the state of the art in the science they had based their concepts on... was significantly incomplete... but didn't seem to generate much immediate potential for big new products and massive revenue.
Early stage drug research and development is a high risk affair. Here, the investors money ended up paying to generate scientific progress... not a blockbuster new drug, which might have resulted were they spot on in their entering assumptions.
It looks to me like they took a good honest swing at it and missed... not for lack of trying or lack of skill... and I don't have any problem with that at all. I didn't make any money here by holding VIAP shares... but, I count it still as one of the more successful failures I've seen and been involved with. This was a really good thing to have allocated and lost a little bit of the high end of the risk pool money on.
I hope they find a way to salvage the remnants that they can and make something of them. I hope they figure it out and solve the new puzzles in a way that lets them hit it out of the park on the next go... and hope those still holding now are able to benefit from that effort in the future...
But, for me, I'm going to wait to see if and how they intend to retool it and refocus it... before deciding that it is worth throwing any more risk $$$ at it. For now, it looks like the primary problem is a disconnect between past expectations and the reality of what they have and where they are... along with the reality of the market we are in. I'm not following the thread in the result from what they learned here in the science project. Until they are ready to talk about that... I don't see what ELSE there is to talk about ?
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM